Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Macrocephaly-spastic paraplegia-dysmorphism syndrome is a rare syndrome of multiple congenital anomalies characterized by macrocephaly (of post-natal onset) with large anterior fontanelle, progressive complex spastic paraplegia, dysmorphic facial features (broad and high forehead, deeply set eyes, short philtrum with thin upper lip, large mouth and prominent incisors), seizures, and intellectual deficit of varying severity. Inheritance appears to be autosomal recessive.
Biomarker and diagnostic research for macrocephaly-spastic paraplegia-dysmorphism syndrome has been reported in the published literature.
Estimated prevalence: Unknown (Unknown prevalence).
No clinical trials have been registered for macrocephaly-spastic paraplegia-dysmorphism syndrome.
204 publications have been identified in PubMed for macrocephaly-spastic paraplegia-dysmorphism syndrome. Research spans Review / Meta-Analysis (53%), Basic Science / Preclinical (16%), and Epidemiology / Natural History (12%).
Research Type | Count | % of Total |
|---|---|---|
Research summaries | 108 | 53% |
Data assembled from 4 of 12 sources · Last updated Sep 20, 2026, 8:41 AM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center
Laboratory research |
33 |
16% |
Disease patterns and progression | 25 | 12% |
Patient case studies | 21 | 10% |
Testing and diagnosis research | 7 | 3% |
New treatment approaches | 6 | 3% |
Clinical study results | 3 | 1% |
Other research | 1 | 0% |
Buckner J (2026). [PMID: 41250525](https://pubmed.ncbi.nlm.nih.gov/41250525/). *Subst Use Misuse*. [Epidemiology / Natural History]
Asghar E (2026). [PMID: 41401403](https://pubmed.ncbi.nlm.nih.gov/41401403/). *Ocul Immunol Inflamm*. [Review / Meta-Analysis]
Buel KL (2026). [PMID: 41569909](https://pubmed.ncbi.nlm.nih.gov/41569909/). *FP Essent*. [Review / Meta-Analysis]
Avelino-Silva TJ (2026). [PMID: 41591773](https://pubmed.ncbi.nlm.nih.gov/41591773/). *JAMA Netw Open*. [Epidemiology / Natural History]
Palaparthi S (2026). [PMID: 42091310](https://pubmed.ncbi.nlm.nih.gov/42091310/). *Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu*. [Review / Meta-Analysis]
Beuriat PA (2026). [PMID: 42115454](https://pubmed.ncbi.nlm.nih.gov/42115454/). *Adv Tech Stand Neurosurg*. [Review / Meta-Analysis]
Anandan S (2026). [PMID: 41818118](https://pubmed.ncbi.nlm.nih.gov/41818118/). *J Assoc Physicians India*. [Case Report / Case Series]
Aguilar AA (2026). [PMID: 41758717](https://pubmed.ncbi.nlm.nih.gov/41758717/). *AACN Adv Crit Care*. [Review / Meta-Analysis]
Anderson EN (2026). [PMID: 41468891](https://pubmed.ncbi.nlm.nih.gov/41468891/). *Am J Hum Genet*. [Basic Science / Preclinical]
Lee S (2026). [PMID: 41206258](https://pubmed.ncbi.nlm.nih.gov/41206258/). *Am J Geriatr Psychiatry*. [Review / Meta-Analysis]